Pfizer: Stagnation Is An Investment Opportunity

Company Overview - Pfizer (NYSE: PFE) is a major pharmaceutical company with a market valuation of $140 billion and offers an almost 7% dividend yield [2]. Financial Performance - The company has experienced stagnation but has maintained its dividend payout since the last recommendation [2]. Investment Strategy - The Value Portfolio focuses on building retirement portfolios through a fact-based research strategy, which includes thorough analysis of 10Ks, analyst commentary, market reports, and investor presentations [2].